Style | Citing Format |
---|---|
MLA | Namkhah Z, et al.. "Does Vitamin C Supplementation Exert Profitable Effects on Serum Lipid Profile in Patients With Type 2 Diabetes? a Systematic Review and Dose-Response Meta-Analysis." Pharmacological Research, vol. 169, no. , 2021, pp. -. |
APA | Namkhah Z, Ashtarylarky D, Naeini F, Clark CCT, Asbaghi O (2021). Does Vitamin C Supplementation Exert Profitable Effects on Serum Lipid Profile in Patients With Type 2 Diabetes? a Systematic Review and Dose-Response Meta-Analysis. Pharmacological Research, 169(), -. |
Chicago | Namkhah Z, Ashtarylarky D, Naeini F, Clark CCT, Asbaghi O. "Does Vitamin C Supplementation Exert Profitable Effects on Serum Lipid Profile in Patients With Type 2 Diabetes? a Systematic Review and Dose-Response Meta-Analysis." Pharmacological Research 169, no. (2021): -. |
Harvard | Namkhah Z et al. (2021) 'Does Vitamin C Supplementation Exert Profitable Effects on Serum Lipid Profile in Patients With Type 2 Diabetes? a Systematic Review and Dose-Response Meta-Analysis', Pharmacological Research, 169(), pp. -. |
Vancouver | Namkhah Z, Ashtarylarky D, Naeini F, Clark CCT, Asbaghi O. Does Vitamin C Supplementation Exert Profitable Effects on Serum Lipid Profile in Patients With Type 2 Diabetes? a Systematic Review and Dose-Response Meta-Analysis. Pharmacological Research. 2021;169():-. |
BibTex | @article{ author = {Namkhah Z and Ashtarylarky D and Naeini F and Clark CCT and Asbaghi O}, title = {Does Vitamin C Supplementation Exert Profitable Effects on Serum Lipid Profile in Patients With Type 2 Diabetes? a Systematic Review and Dose-Response Meta-Analysis}, journal = {Pharmacological Research}, volume = {169}, number = {}, pages = {-}, year = {2021} } |
RIS | TY - JOUR AU - Namkhah Z AU - Ashtarylarky D AU - Naeini F AU - Clark CCT AU - Asbaghi O TI - Does Vitamin C Supplementation Exert Profitable Effects on Serum Lipid Profile in Patients With Type 2 Diabetes? a Systematic Review and Dose-Response Meta-Analysis JO - Pharmacological Research VL - 169 IS - SP - EP - PY - 2021 ER - |